SGLT2 inhibition via dapagliflozin improves generalized vascular dysfunction and alters the gut microbiota in type 2 diabetic mice
出版年份 2018 全文链接
标题
SGLT2 inhibition via dapagliflozin improves generalized vascular dysfunction and alters the gut microbiota in type 2 diabetic mice
作者
关键词
SGLT2, Dapagliflozin, Vascular function, Arterial stiffness, Aortic pulse wave velocity, Type 2 diabetes, Gut microbiota
出版物
Cardiovascular Diabetology
Volume 17, Issue 1, Pages -
出版商
Springer Nature
发表日期
2018-04-27
DOI
10.1186/s12933-018-0708-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Suppression of gut dysbiosis reverses Western diet-induced vascular dysfunction
- (2018) Micah L. Battson et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Chitosan oligosaccharides improve the disturbance in glucose metabolism and reverse the dysbiosis of gut microbiota in diabetic mice
- (2018) Junping Zheng et al. CARBOHYDRATE POLYMERS
- Empagliflozin rescues diabetic myocardial microvascular injury via AMPK-mediated inhibition of mitochondrial fission
- (2018) Hao Zhou et al. Redox Biology
- Extensive impact of non-antibiotic drugs on human gut bacteria
- (2018) Lisa Maier et al. NATURE
- Tauroursodeoxycholic Acid Reduces Arterial Stiffness and Improves Endothelial Dysfunction in Type 2 Diabetic Mice
- (2017) Micah L. Battson et al. JOURNAL OF VASCULAR RESEARCH
- MicrobiomeAnalyst: a web-based tool for comprehensive statistical, visual and meta-analysis of microbiome data
- (2017) Achal Dhariwal et al. NUCLEIC ACIDS RESEARCH
- Effects of Antidiabetic Drugs on Gut Microbiota Composition
- (2017) et al. Genes
- Statin therapy causes gut dysbiosis in mice through a PXR-dependent mechanism
- (2017) Jose A. Caparrós-Martín et al. Microbiome
- Akkermansia MuciniphilaProtects Against Atherosclerosis by Preventing Metabolic Endotoxemia-Induced Inflammation inApoe−/−MiceCLINICAL PERSPECTIVE
- (2016) Jin Li et al. CIRCULATION
- Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus
- (2016) Hiddo J.L. Heerspink et al. CIRCULATION
- SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?
- (2016) Naveed Sattar et al. DIABETOLOGIA
- The SGLT-2 Inhibitor Dapagliflozin Has a Therapeutic Effect on Atherosclerosis in Diabetic ApoE−/−Mice
- (2016) Weiling Leng et al. MEDIATORS OF INFLAMMATION
- DADA2: High-resolution sample inference from Illumina amplicon data
- (2016) Benjamin J Callahan et al. NATURE METHODS
- Vascular microRNA-204 is remotely governed by the microbiome and impairs endothelium-dependent vasorelaxation by downregulating Sirtuin1
- (2016) Ajit Vikram et al. Nature Communications
- myPhyloDB: a local web server for the storage and analysis of metagenomic data
- (2016) Daniel K. Manter et al. Database-The Journal of Biological Databases and Curation
- Impact of the gut microbiota on inflammation, obesity, and metabolic disease
- (2016) Claire L. Boulangé et al. Genome Medicine
- VSEARCH: a versatile open source tool for metagenomics
- (2016) Torbjørn Rognes et al. PeerJ
- Interactions between host genetics and gut microbiome in diabetes and metabolic syndrome
- (2016) Siegfried Ussar et al. Molecular Metabolism
- Aortic perivascular adipose-derived interleukin-6 contributes to arterial stiffness in low-density lipoprotein receptor deficient mice
- (2015) Bing Du et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- SGLT inhibitors attenuate NO-dependent vascular relaxation in the pulmonary artery but not in the coronary artery
- (2015) Ying Han et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- The gut microbiome in health and in disease
- (2015) Andrew B. Shreiner et al. CURRENT OPINION IN GASTROENTEROLOGY
- Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association
- (2015) Caroline S. Fox et al. DIABETES CARE
- Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes
- (2015) R. Chilton et al. DIABETES OBESITY & METABOLISM
- The relationship between arterial stiffness and heart failure with preserved ejection fraction: a systemic meta-analysis
- (2015) Bryan Chow et al. HEART FAILURE REVIEWS
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Metformin on Metabolic Improvement and Gut Microbiota
- (2014) Heetae Lee et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice
- (2014) Bowen Lin et al. Cardiovascular Diabetology
- Role of Endothelial Dysfunction and Arterial Stiffness in the Development of Diabetic Retinopathy: Figure 1
- (2014) Gerasimos Siasos et al. DIABETES CARE
- Modeling effects of SGLT-2 inhibitor dapagliflozin treatment versus standard diabetes therapy on cardiovascular and microvascular outcomes
- (2014) J. Dziuba et al. DIABETES OBESITY & METABOLISM
- Endothelial Dysfunction Plays a Key Role in Increasing Cardiovascular Risk in Type 2 Diabetes
- (2014) Thomas T. van Sloten et al. HYPERTENSION
- Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus
- (2014) Daniel Lorber Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Diabetes, obesity and gut microbiota
- (2013) Amandine Everard et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Effects of SGLT2 selective inhibitor ipragliflozin on hyperglycemia, hyperlipidemia, hepatic steatosis, oxidative stress, inflammation, and obesity in type 2 diabetic mice
- (2013) Atsuo Tahara et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- An increase in theAkkermansiaspp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice
- (2013) Na-Ri Shin et al. GUT
- Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
- (2013) A. Everard et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of Type 2 diabetes
- (2012) Mona Sedeek et al. CLINICAL SCIENCE
- Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms
- (2012) J Gregory Caporaso et al. ISME Journal
- The Intestinal Microbiota and Obesity
- (2011) Samuel J. Kallus et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants
- (2011) Goodarz Danaei et al. LANCET
- Metagenomic biomarker discovery and explanation
- (2011) Nicola Segata et al. GENOME BIOLOGY
- Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials
- (2008) Jay S. Skyler et al. CIRCULATION
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now